Evidence map›Paper›PMID 26870663›Full record

ArticleJournal of neuromuscular diseases

Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.

Amina Chaouch, Vito Porcelli, Daniel Cox, Shimon Edvardson, Pasquale Scarcia, Anna De Grassi, Ciro L Pierri, Judith Cossins, Steven H Laval, Helen Griffin and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuromuscular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Congenital myasthenic syndromes.Orphanet journal of rare diseases · 2019
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. From the cytosol to the inner membrane: biogenesis of the mitochondrial carrier family.Protein science : a publication of the Protein Society · 2026
    Review
  9. Review
  10. Diffuse pacemaker mechanism with distinctive organization drives pulsation in the octocoralProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Article
  13. Modeling of Charcot-Marie-Tooth disease in zebrafish.Frontiers in molecular neuroscience · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 4 countries.

Amina ChaouchInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Vito PorcelliDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Bari, Italy.
Daniel CoxInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Shimon EdvardsonMonique and Jacques Roboh Department of Genetic Research, Hadassah, Hebrew University Medical Center, Jerusalem, Israel.
Pasquale ScarciaDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Bari, Italy.
Anna De GrassiDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Bari, Italy.
Ciro L PierriDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Bari, Italy.
Judith CossinsNeurosciences Group, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
Steven H LavalInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Helen GriffinInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Juliane S MüllerInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Teresinha EvangelistaInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Ana TöpfInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Angela AbichtMedizinisch Genetisches Zentrum, Munich, Germany ; Friedrich-Baur-Institut, Ludwig Maximilians University, Munich, Germany.
Angela HuebnerChildren's Hospital, Technical University Dresden, Dresden, Germany.
Maja von der HagenChildren's Hospital, Technical University Dresden, Dresden, Germany.
Kate BushbyInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Volker StraubInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Rita HorvathInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Orly ElpelegMonique and Jacques Roboh Department of Genetic Research, Hadassah, Hebrew University Medical Center, Jerusalem, Israel.
Jacqueline PalaceDepartment of Clinical Neurology, The John Radcliffe, Oxford, UK.
Jan SenderekFriedrich-Baur-Institut, Ludwig Maximilians University, Munich, Germany.
David BeesonNeurosciences Group, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
Luigi PalmieriDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Bari, Italy ; CNR Institute of Biomembranes and Bioenergetics, Bari, Italy.
Hanns LochmüllerInstitute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, Newcastle upon Tyne, UK.
Newcastle University · GBUniversity of Bari Aldo Moro · ITJohn Radcliffe Hospital · GBHadassah Medical Center · ILTechnische Universität Dresden · DEFriedrich Baur Stiftung · DEInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITMedical Genetics Center · DE

Funding

Medical Research Council G1002274
6 · The paper itself

Abstract

BACKGROUND AND

objectiveCongenital myasthenic syndromes are rare inherited disorders characterized by fatigable weakness caused by malfunction of the neuromuscular junction. We performed whole exome sequencing to unravel the genetic aetiology in an English sib pair with clinical features suggestive of congenital myasthenia.

methodsWe used homozygosity mapping and whole exome sequencing to identify the candidate gene variants. Mutant protein expression and function were assessed

resultsWe identified a novel homozygous missense mutation in the

conclusionsBased on the axonal outgrowth defects seen in SLC25A1 knockdown zebrafish, we hypothesize that the neuromuscular junction impairment may be related to pre-synaptic nerve terminal abnormalities. Our findings highlight the complex machinery required to ensure efficient neuromuscular function, beyond the proteomes exclusive to the neuromuscular synapse.

Indexed as

Congenital myasthenic syndromemitochondrial citrate carrierneuromuscular junctionSLC25A1

Identifiers

PMID26870663
PMCPMC4746751
OpenAlexW1715970343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.